23 completed. 23 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 23 | Completed 23 |
| Phase 2 | 3 | Completed 3 |
Follow Corticosteroid: new trials by email Literature Review of Corticosteroid trials Research Report on Corticosteroid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis Microfragmented Adipose Tissue, Corticosteroid - Knee Osteoarthritis, Osteo Arthritis Knee | Phase 3 | Completed | Lipogems International spa | 173 | 2022-12-30 | 2025-04-22 |
| MTX and Steroid as First-line Therapy for aGVHD MTX, Corticosteroid - Acute GVH Disease | Phase 3 | Completed | Peking University People's Hospital | 157 | 2021-06-25 | 2025-06-03 |
| Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) Aviptadil, Aviptadil Placebo, Corticosteroid - Covid19 | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 471 | 2021-04-20 | 2025-10-09 |
| ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 Remdesivir, Remdesivir Placebo, Aviptadil - Covid19 | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 473 | 2021-04-20 | 2025-10-24 |
| Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial) Remdesivir, Remdesivir Placebo, Corticosteroid - Covid19 | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 87 | 2021-04-20 | 2025-10-09 |
| Comparative Effect of Nigella Sativa and Conventional Management for OSMF Nigella sativa oil, Betamethasone Valerate - Oral Submucous Fibrosis | Phase 3 | Completed | Ziauddin University | 39 | 2021-02-11 | 2022-03-15 |
| Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, Corticosteroid - Osteo Arthritis Knee | Phase 2 / Phase 3 | Completed | Queen Savang Vadhana Memorial Hospital, Thailand | 93 | 2020-08-03 | 2023-02-21 |
| Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis Sirolimus, Corticosteroid - Retroperitoneal Fibrosis | Phase 2 / Phase 3 | Completed | Peking University International Hospital | 64 | 2018-07-01 | 2026-09-22 |
| Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa DF289 plus DF277, DF289, DF277 - Acute Otitis Externa | Phase 3 | Completed | Salvat | 493 | 2017-07-22 | 2021-04-09 |
| Corticosteroids for Children With Febrile Urinary Tract Infections Placebo, Dexamethasone - Acute Urinary Tract Infection, Urinary Tract Infection | Phase 3 | Completed | Nader Shaikh | 546 | 2011-09-01 | 2019-07-02 |
| Platelet-rich Plasma Intra-articular Knee Injections for Knee Osteoarthritis platelet-rich plasma, Corticosteroid - Knee Osteoarthritis | Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 74 | 2011-07-01 | 2015-02-24 |
| Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial Betamethasone, Placebo - Pregnancy, Respiratory Distress Syndrome | Phase 3 | Completed | The George Washington University Biostatistics Center | 2831 | 2010-10-01 | 2023-03-28 |
| Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids Everolimus, Mycophenolate mofetil (MMF), Basiliximab - Kidney Transplantation | Phase 3 | Completed | Novartis | 122 | 2008-02-01 | 2013-06-21 |
| Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) Prochymal®, Placebo, Corticosteroid - Graft Versus Host Disease | Phase 3 | Completed | Mesoblast, Inc. | 192 | 2008-01-31 | 2022-01-19 |
| Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema Triamcinolone Acetonide + laser, Ranibizumab + laser, Sham injection + laser - Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Completed | Jaeb Center for Health Research | 691 | 2007-03-01 | 2019-10-07 |
| Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy Ranibizumab, Triamcinolone Acetonide, Sham injection - Proliferative Diabetic Retinopathy, Diabetic Macular Edema | Phase 3 | Completed | Jaeb Center for Health Research | 333 | 2007-03-01 | 2016-08-26 |
| ORTHOVISC Shoulder Osteoarthritis Study Orthovisc, Control - Glenohumeral Osteoarthritis | Phase 3 | Completed | DePuy Mitek | 274 | 2006-12-01 | 2017-03-09 |
| Efficacy of Pentoxifylline on Primary Nephrotic Syndrome pentoxifylline, Corticosteroid - Nephrotic Syndrome | Phase 3 | Completed | National Taiwan University Hospital | 62 | 2006-08-01 | 2012-11-14 |
| A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. Mycophenolate mofetil (MMF), Cyclophosphamide, Azathioprine - Lupus Nephritis | Phase 3 | Completed | Hoffmann-La Roche | 370 | 2005-07-01 | 2011-12-06 |
| Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema Standard of Care Group, 1mg triamcinolone acetonide, 4mg triamcinolone acetonide - Diabetic Macular Edema | Phase 3 | Completed | Jaeb Center for Health Research | 840 | 2004-07-01 | 2016-08-26 |
Showing 20 of 23. Sign in to see all of them.
COVID-19 (3) · Coronaviridae Infections (3) · Coronavirus Infections (3) · Nidovirales Infections (3) · Osteoarthritis, Knee (3) · RNA Virus Infections (3) · Severe Acute Respiratory Syndrome (3) · Virus Diseases (3) · Diabetic Retinopathy (2) · Dysferlinopathy (1) · Edema (1) · Graft vs Host Disease (1) · Limb-girdle muscular dystrophy, type 2B (1) · Lupus Nephritis (1) · Miyoshi myopathy (1)
Jaeb Center for Health Research (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · DePuy Mitek (1) · Hoffmann-La Roche (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Lipogems International spa (1) · Ludwig-Maximilians - University of Munich (1) · Mesoblast, Inc. (1) · Nader Shaikh (1) · National Institute on Deafness and Other Communication Disorders (NIDCD) (1) · National Taiwan University Hospital (1) · Novartis (1) · Peking University International Hospital (1) · Peking University People's Hospital (1) · Queen Savang Vadhana Memorial Hospital, Thailand (1)
United States (13) · China (3) · Germany (3) · Spain (3) · Australia (2) · Canada (2) · Argentina (1) · Belgium (1) · Brazil (1) · Czechia (1) · France (1) · Greece (1) · Hungary (1) · Italy (1) · Japan (1)
Prof. James Neaton (3) · Samuel Brown, MD (3) · Alexander J. Brucker, M.D. (1) · Andrea Ladwig (1) · Christopher James, PA (1) · Cynthia Gyamfi Bannerman, MD (1) · Dr. Tasnee Chonmaitree (1) · Hira Batool, Mphil (1) · Hui Gao, Doctor (1) · Jonathan B. McGlohorn (1) · Joseph Googe, Jr., M.D. (1) · Maggie C. Walter, MD (1) · Michael Ip, M.D. (1)
PMID 21571677, PMID 20008710, PMID 20427088, PMID 22999634, PMID 25439614, PMID 26802783, PMID 12081113, PMID 17765429, PMID 18662829, PMID 18698292, PMID 19273785, PMID 1991946, PMID 19933596, PMID 20008708, PMID 20039429, PMID 20122739, PMID 21080348, PMID 21459214, PMID 22087680, PMID 22922564, PMID 23406536, PMID 23866828, PMID 25035839, PMID 25161985, PMID 25925602, PMID 26432430, PMID 26842679, PMID 28012636, PMID 28386761, PMID 30623236, PMID 30632533, PMID 32556960, PMID 33206392, PMID 33368142, PMID 34251495, PMID 34825704, PMID 34826301, PMID 35103547, PMID 35618748, PMID 35834251, PMID 36695483, PMID 36774994, PMID 37348524, PMID 38664766
U10EY014229 (3), U10EY014231 (3), U10EY018817 (3), R01DC002620 (1), R01DK087870 (1), U01HL098354 (1), U01HL098554 (1), U10HD021410 (1), U10HD027869 (1), U10HD027915 (1), U10HD027917 (1), U10HD034116 (1), U10HD034208 (1), U10HD036801 (1), U10HD040485 (1)